Huapont Life Sciences subsidiary obtained the registration certificate for the cream product of mometasone furoate.
HuaBang Health (002004.SZ) announcement, the company's wholly-owned subsidiary Chongqing HuaBang Pharmaceutical Co., Ltd. (referred to as "HuaBang...
Huapont Life Sciences (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd. (referred to as "Huabang Pharmaceutical"), recently received two specifications of the "Drug Registration Certificate" for its clobetasone butyrate cream approved and issued by the National Medical Products Administration. Clobetasone butyrate cream is mainly used for eczema, neurodermatitis, atopic dermatitis, and itching.
Related Articles
One of the actual controllers of Luxshare Precision Industry (002475.SZ), Wang Laisheng, has completed an increase in shareholding, with a total increase of 4.4145 million shares.
China Lesso Group Holdings Limited reduced its holdings in Red Star Macalline Group Corporation (01528) by 2.6304 million shares at an average price of approximately 1.57 Hong Kong dollars per share.
Chen Canlin increased his holdings in TIAN CHANG GP (02182) by 28,000 shares, with an average price of HK$0.385 per share.
One of the actual controllers of Luxshare Precision Industry (002475.SZ), Wang Laisheng, has completed an increase in shareholding, with a total increase of 4.4145 million shares.
China Lesso Group Holdings Limited reduced its holdings in Red Star Macalline Group Corporation (01528) by 2.6304 million shares at an average price of approximately 1.57 Hong Kong dollars per share.
Chen Canlin increased his holdings in TIAN CHANG GP (02182) by 28,000 shares, with an average price of HK$0.385 per share.
